Event with Michael J. Gelb
The Art of Connection: 7 Relationship Building Skills Every Leader Needs Now
Friday, October 12, 2018
6 – 9 p.m.
Cleveland Museum of Art
11150 East Boulevard, Cleveland
CONTINUING MEDICAL EDUCATION
Saturday, October 13, 2018
7 a.m. – 4 p.m.
Hilton Cleveland Downtown
100 Lakeside Avenue East, Cleveland
Cardiovascular disease (CVD) is the leading cause of death in the United States for both men and women, claiming approximately 800,000 lives annually. Treatment approaches are helping prolong life with improved quality in many patients with advanced heart disease. During this symposium, we will provide an in-depth overview of current advances in the care of complex patients with cardiovascular disease. At the end of this case-based symposium, practitioners should be able to incorporate many of the tips and tools into their daily practice.
- Hot Topics in Complex Cardiovascular Care
- Cutting Edge Diagnostic Tools and Novel Management Strategies
- Internationally Acclaimed Speakers and Panelists
- Interactive Case-Based Symposium and Plenary Sessions
- Pre-Symposium Leadership Event (requires separate registration)
- Upon completion of this activity, participants will be able to:
- Examine the impact of emerging treatment approaches in complex patients with structural heart disease, arrhythmias, heart failure and vascular disease
- Assess the latest diagnostic approaches to help guide treatment
- Review the latest information in preventive cardiology
- Utilize guideline and evidence-based strategies to lower risk
WHO SHOULD ATTEND
The intended audience for this activity are cardiologists, internists, family practitioners, nurse practitioners and physician assistants.
Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Case Western Reserve University School of Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve University School of Medicine CME Program also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.
This program will be supported by grants from industry. A complete list of supporters will be provided in the syllabus materials distributed at the meeting. Acceptance of funding in support of this program does not constitute endorsement of any product or manufacturer.
Hilton Cleveland Downtown, 100 Lakeside Avenue East, Cleveland
7 – 7:30 a.m. Registration and Continental Breakfast
7:30 – 7:35 a.m.
Marco Costa, MD, PhD and Sanjay Rajagopalan, MD
TRACK ONE: MEDICAL AND DEVICE THERAPIES FOR MANAGING HEART FAILURE
Moderator: Guilherme Oliveira, MD
Panel: Michael Zacharias, DO and Benjamin Medalion, MD
7:35 – 7:40 a.m. Track One Anchor Case
Monique Robinson, MD, PhD
7:40 – 8:10 a.m. Plenary Lecture 1: Novel Pharmacologic Approaches for Heart Failure
Clyde Yancy, MD
8:10 – 8:30 a.m. Optimizing Structural and Mechanical Function in Advanced HFREF: What Can We Do in 2018 and Beyond?
Mandeep Mehra, MD
8:30 – 8:50 a.m. Personalized Intervention in the Patient with Recurrent HF Hospitalization
Adrian Hernandez, MD
8:50 – 9 a.m. Discussion and Q&A
TRACK TWO: CARDIOVASCULAR PREVENTION
Moderators: Barry Effron, MD and Chris Longenecker, MD
Panel: Goutham Rao, MD and David Zidar, MD, PhD
9 – 9:05 a.m. Track Two Anchor Case
Claire Sullivan, MD
9:05 – 9:35 a.m. Plenary Lecture 2: Evolving Progress of Atherothrombotic Therapies
Paul Ridker, MD
9:35 – 9:55 a.m. Advanced Imaging Based Assessment of Cardiovascular Disease Risk
James Min, MD
9:55 – 10:15 a.m. GLP-1 Agonists in the High-Risk Diabetics: What the PCP and Cardiologist Need to Know
Sanjay Rajagopalan, MD
10:15 – 10:35 a.m. Weight Loss Interventions in Overweight Diabetics
Goutham Rao, MD
10:35 – 10:45 a.m. Discussion and Q&A
10:45 – 11 a.m. BREAK: Refreshments and Exhibits
TRACK THREE: RESTORING STRUCTURAL HEART AND VASCULAR FUNCTION
Moderators: Guilherme Attizzani, MD and Alan Markowitz, MD
Panel: Ankur Kalra, MD, Daniel Simon, MD and Christopher Snyder, MD
11 – 11:05 a.m. Track Three Anchor Case
Farshad Forouzandeh, MD
11:05 – 11:25 a.m. Mechanical Therapies in the Patient with Shock: When to Use What?
Mir Basir, MD
11:25 – 11:45 a.m. The Next Frontier of TAVR and Mitral Interventions: Who, When and What?
Jean Claude Laborde, MD
11:45 a.m. – 12:05 p.m. Post PCI Optimal DAPT Duration in STEMI/NSTEMI/Stable CAD
Laura Mauri, MD
12:05 – 12:25 p.m. Adult Congenital Structural Interventions: Innovation Where the Sidewalk Ends
Martin Bocks, MD
12:25 – 12:35 p.m. Discussion and Q&A
12:35 – 1:25 p.m. BREAK: Exhibits and Boxed Lunch
TRACK FOUR: MAKING A DIFFERENCE IN PATIENTS WITH VASCULAR & LYMPHATIC DISEASE
Moderators: Mehdi Shishehbor, DO, PhD and Vikram Kashyap, MD
Panel: Jun Li, MD and Christopher Smith, MD
1:25 – 1:30 p.m. Track Four Anchor Case
Jun Li, MD
1:30 – 1:50 p.m. Paradigm Change in the Management of PAD
Marc Bonaca, MD
1:50 – 2:10 p.m. CLI: Recent Advances in Diagnosis and Limb Salvage
Mehdi Shishehbor, DO, PhD
2:10 – 2:30 p.m. Pulmonary Embolism in 2018: Perking up PERT Teams and Systemic Treatment
Aditya Sharma, MD
2:30 – 2:40 p.m. Discussion and Q&A
TRACK FIVE: STATE OF THE ART CONCEPTS IN ELECTRICAL DISORDERS
Moderators: Mauricio Arruda, MD and Albert Waldo, MD
Panel: Dev Venugopal, MD and Ivan Cakulev, MD
2:40 – 2:45 p.m. Track Five Anchor Case
Antonio Sotolongo, MD
2:45 – 3:05 p.m. Atrial Fibrillation in 2018: What are the Long Term Results and What to Do with Anticoagulation
Mauricio Arruda, MD
3:05 – 3:25 p.m. Ventricular Tachycardia and Catheter Ablation: Who, When and How?
Kalyanam Shivkumar, MD, PhD
3:25 – 3:45 p.m. Innovations in Device Therapies: SubQ ICDs and Leadless Pacers
Judith Mackall, MD
3:45 – 3:55 p.m. Discussion and Q&A
3:55 – 4 p.m. Closing Remarks
Daniel Simon, MD